Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 7/20 | 0.42 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.42 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.42 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 5/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL502062 | 0.97 | ALDH1A1 (0.42) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 | |
| SCHEMBL10009881 | 0.85 | ALDH1A1 (0.45) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 | |
| SCHEMBL2710223 | 0.81 | LPAR3 (0.43) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 | |
| SCHEMBL9054631 | 0.80 | ALDH1A1 (0.61) | ALDH1A1LMNACYP3A4SLC22A6TSHR | |
| SCHEMBL27692979 | 0.79 | ALDH1A1 (0.43) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 | |
| SCHEMBL1877200 | 0.79 | ALDH1A1 (0.43) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 | |
| SCHEMBL27566719 | 0.79 | LPAR3 (0.41) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 | |
| Hydrochloric Acid SCHEMBL22189200 | 0.79 | LPAR3 (0.41) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 | |
| SCHEMBL5472579 | 0.79 | TSHR (0.55) | ALDH1A1TSHRHDAC3HDAC1HDAC2 | |
| SCHEMBL8028544 | 0.77 | ALDH1A1 (0.46) | ALDH1A1LMNAEGLN1ALKBH5SUCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118496222-A | Selenium-containing melanin and preparation method and application thereof | 北京师范大学 | 2024-08-16 | — | — | CN | claimed |
| CN-116064959-A | Colorimetric sensor and kit based on CRISPR-Cas12a and application of colorimetric sensor and kit in detection of viral nucleic acid | 山东师范大学 | 2023-05-05 | — | — | CN | claimed |
| CN-115286958-B | Biomass-based antifouling material and application thereof | 陕西师范大学 | 2023-04-07 | — | — | CN | claimed |
| CN-115286958-A | Biomass-based antifouling material and application thereof | 陕西师范大学 | 2022-11-04 | — | — | CN | claimed |
| CN-112876862-B | Nano ferroferric oxide/bovine serum albumin composite material, preparation method and application | 西安理工大学 | 2022-05-17 | — | — | CN | claimed |
| CN-113897414-A | Trace nucleic acid library construction method | 湖南大地同年生物科技有限公司 | 2022-01-07 | — | — | CN | claimed |
| CN-112876862-A | Nano ferroferric oxide/bovine serum albumin composite material, preparation method and application | 西安理工大学 | 2021-06-01 | — | — | CN | claimed |
| CN-112264272-A | Multifunctional natural super-hydrophobic material and application thereof | 陕西师范大学 | 2021-01-26 | — | — | CN | claimed |
| CN-107573530-B | Preparation method of lysozyme composite food packaging film | 西安理工大学 | 2020-08-18 | — | — | CN | claimed |
| CN-111135345-A | Dental implant material and preparation method thereof | 吴俊江 | 2020-05-12 | — | — | CN | claimed |
| WO-2026097979-A1 | FLAME-RETARDANT MATERIAL, AND PREPARATION METHOD THEREFOR AND PRODUCT THEREOF | 江苏博云塑业股份有限公司 | 2026-05-15 | — | — | WO | disclosed |
| US-12583920-B2 | Compositions and methods for treatment and prevention of Alzheimer's disease | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2026-03-24 | — | — | US | disclosed |
| US-20260015332-A1 | SYNTHESIS METHOD AND APPLICATION OF BENZOTHIASELENAZOLE-1-OXIDE COMPOUND AND DERIVATIVE THEREOF | GUANGZHOU MEDICAL UNIVERSITY (CN) | 2026-01-15 | — | — | US | disclosed |
| CN-120081920-A | Disulfide bond-containing polypeptide and preparation method and application thereof | 中国科学院上海药物研究所 | 2025-06-03 | — | — | CN | disclosed |
| CN-120078709-A | Multifunctional nano hydrogel and preparation method and application thereof | 上海交通大学医学院附属第九人民医院 | 2025-06-03 | — | — | CN | disclosed |
| US-20080207541-A1 | Contacting a eukaryotic cell with a mixed backbone oligonucleotide with a first region that forms a substrate for cleavage by an RNase and a second region which does not, and a transition moiety which modulates the transmission of the conformation of said second region into the first region | IONIS PHARMACEUTICALS, INC. | 2008-08-28 | — | — | US | disclosed |
| US-20080118916-A1 | SEQUENTIAL ANALYSIS OF BIOLOGICAL SAMPLES | GENERAL ELECTRIC COMPANY (US) | 2008-05-22 | — | — | US | disclosed |
| EP-1730309-A2 | COMPOSITIONS AND METHODS FOR OPTIMIZING CLEAVAGE OF RNA BY RNASE H | Isis Pharmaceuticals, Inc. (US) | 2006-12-13 | — | — | EP | disclosed |
| WO-2005089268-A2 | COMPOSITIONS AND METHODS FOR OPTIMIZING CLEAVAGE OF RNA BY RNASE H | ISIS PHARMACEUTICALS, INC. (US) | 2005-09-29 | — | — | WO | disclosed |
| US-6657196-B2 | Method and apparatus for environmental monitoring | ADVANTEST CORP. (JP) | 2003-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207541-A1 | Contacting a eukaryotic cell with a mixed backbone oligonucleotide with a first region that forms a substrate for cleavage by an RNase and a second region which does not, and a transition moiety which modulates the transmission of the conformation of said second region into the first region | RNASEH1, NSUN3, RNASEL | ALDH1A1 3259/4885LMNA 453/4885EGLN1 1093/4885 |
| US-12583920-B2 | Compositions and methods for treatment and prevention of Alzheimer's disease | APP, MAPT, LRP6 | ALDH1A1 3125/4885LMNA 1753/4885EGLN1 4724/4885 |
| US-20260015332-A1 | SYNTHESIS METHOD AND APPLICATION OF BENZOTHIASELENAZOLE-1-OXIDE COMPOUND AND DERIVATIVE THEREOF | SARS1, EGFR, ERBB2 | ALDH1A1 2251/4885LMNA 4526/4885EGLN1 4017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.